Celldex Therapeutics, Inc. (CLDX) Stock
NASDAQ · CLDX
37.89
Fundamentals
Market cap
$3.00B
Price / Earnings ratio
-10.0x
Price / Sales ratio
19006.3x
Price / Book ratio
4.2x
Return on assets
-0.5%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A
Latest news
About Celldex Therapeutics, Inc.
No description available.
SectorHealthcare
IndustryBiotechnology
Employees198
CEOMr. Anthony S. Marucci M.B.A.
IPO DateMar 10, 2008
HeadquartersHampton, NJ
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Anthony S. Marucci M.B.A. | Founder, President, CEO & Director | 1962 |
| Dr. Tibor Keler Ph.D. | Founder, Chief Scientific Officer & Executive VP | 1959 |
| Mr. Sam Martin CPA | Senior VP, CFO, Secretary & Treasurer | 1971 |
| Ms. Elizabeth Crowley | Chief Product Development Officer & Senior VP | 1972 |
| Dr. Margo Heath-Chiozzi M.D. | Senior Vice President of Regulatory Affairs | 1957 |
| Prof. Joseph P. Schlessinger Ph.D. | Co-Founder & Member of Scientific Advisory Board | 1945 |
| Ms. Sarah Cavanaugh | Senior Vice President of Corporate Affairs & Administration | 1975 |
| Mr. Freddy A. Jimenez Esq. | Senior VP & General Counsel | 1969 |
| Dr. Ronald A. Pepin Ph.D. | Chief Business Officer & Senior VP | 1956 |
| Dr. Diane C. Young M.D. | Senior VP & Chief Medical Officer | 1957 |
Fundamentals
Valuation
Market cap$3.00B
Price-to-sales ratio19,006.33
Price-to-book value4.20
Price-earnings ratio-10.00
Return on Equity-51.00%
Return on SalesN/A
Return on AssetsN/A
PEG ratio0.00
Earnings Per Share
Earnings Per Share$-4.36
Income Statement
Average volume761,185
EBITDA$-280.28M
1 year high (52w)$45.14
1 year low (52w)$22.10
Dividend
Ex dividend dateN/A
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



